Abstract
Aims To investigate: (1) alcohol use during the pandemic in the UK; and (2) the extent to which poor inhibitory control and/or stress were associated with any change in alcohol use or hazardous drinking.
Design Cross-sectional online survey administered between 2 and 31 May 2020.
Setting UK.
Participants 13,453 respondents aged 19 – 62 years comprising participants of four nationally representative birth cohorts (19, 30, 50 and 62-years old).
Measurements Change in alcohol use and risk of alcohol-related harm due to hazardous drinking and change in stress since the start of the Coronavirus outbreak; inhibitory control (impatience and risk-taking); and sociodemographic characteristics, including diagnosed or suspected COVID-19, and key worker status.
Findings Most respondents reported consuming/feeling the same amount or less alcohol/stress. However, a significant minority, particularly among thirty-(29.08%) and fifty-year-olds (26.67%), reported drinking more, and between 32.23% and 45.02% of respondents reported feeling more stressed depending on cohort. Being female was associated with an increased likelihood of reporting heightened stress (OR19 = 1.54, 95% CI 1.08 to 2.20; OR30 = 1.93, 95% CI 1.39 to 2.70; OR50 = 1.62, 95% CI 1.37 to 1.92; OR62 = 2.03, 95% CI 1.66 to 2.48). Stress was associated with hazardous drinking among 30-year-olds (OR = 3.77, 95% CI 1.15 to 12.28). Impatience was associated with both increased alcohol use (1.14, 95% CI 1.06, 1.24) and hazardous drinking (1.20, 95% CI 1.05, 1.38) among 19-year-olds. Risk-taking was associated with hazardous drinking for 30-year-olds (OR = 1.18, 95% CI 1.05, 1.32).
Conclusions These data highlight concerns about the UK government’s stance on the ‘essential’ nature of off-premises alcohol sales during the lockdown, particularly from a public health perspective, when considering those at risk of alcohol misuse and alcohol-related harm.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JMC is funded by an ESRC Doctoral Training Partnership grant. MOP receives funding from the Foundation for Liver Research. The funders had no role in study design, data analysis, data interpretation, writing of the report, or the decision to submit for publication. The UCL Centre for Longitudinal Studies, who administered the survey, played no role in the analysis of the data, preparation of the manuscript, or decision to submit the manuscript for publication. All authors had full access to all data in the study. All authors were responsible for the decision to submit for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data used in this work were from the UK Data Service. The registration for the access to the data from UK Data Service was done via University of Portsmouth. Access to the data was given by UK Data Service with the Project Number: 197137. As a secondary analysis was carried out, full ethical review was not required. Thus, the University of Portsmouth Ethics Screening Tool was used for assessment (reference number: ETHICS-10155).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest: None.
Updated manuscript and supplementary materials.
Data Availability
All data used in this study are available from the UK Data Service Website (https://ukdataservice.ac.uk/) under the "Safeguarded" data access policy. The primary dataset used is referenced under study number 8658. Ethnicity data associated with the MCS, Next Steps, BCS70, and NCDS cohorts are referenced under study numbers 6073, 5545, 5558, and 5565 respectively. All analysis code is available on the Open Science Framework website (https://osf.io/wf2rj/).
